Cancer – AHEP1531: A Phase 2/3 Study, Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Condition or Therapy:
Hepatocellular Carcinoma (HCC), Hepatoblastoma (HB),
Cancer and Blood Disorders
Study Number: AHEP1531
What is the goal of this study?
This phase 2/3 trial studies how well, in combination with surgery, cisplatin and combination chemotherapy works in treating children and young adults with hepatoblastoma or hepatocellular carcinoma.
Who can join the study?
This study may be a good fit for children and young adults who:
- are up to 30 years old, and
- have been newly diagnosed with primary pediatric hepatic malignancies including hepatoblastoma or hepatocellular carcinoma.
What will happen if my child takes part in this study?
You can read more about this study on clinicaltrials.gov.
Who can I contact for more information?
To learn more, call 206-987-2106 or email the study coordinator.